Shares of Orion OYJ Unsponsored ADR (OTCMKTS:ORINY - Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $41.33 and last traded at $41.33, with a volume of 211 shares changing hands. The stock had previously closed at $38.88.
Orion OYJ Stock Performance
The stock has a market cap of $11.71 billion, a PE ratio of 28.23 and a beta of 0.10. The firm's 50-day moving average is $36.54 and its 200 day moving average is $31.06. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.27 and a current ratio of 3.79.
Orion OYJ (OTCMKTS:ORINY - Get Free Report) last posted its quarterly earnings data on Friday, July 18th. The company reported $0.33 earnings per share for the quarter. Orion OYJ had a net margin of 22.61% and a return on equity of 38.40%. The business had revenue of $472.57 million during the quarter. As a group, research analysts anticipate that Orion OYJ Unsponsored ADR will post 1.18 EPS for the current year.
About Orion OYJ
(
Get Free Report)
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
See Also
Before you consider Orion OYJ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orion OYJ wasn't on the list.
While Orion OYJ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
